ApprovalTrail

Approval · Notice of Compliance 5375 · 1994

EMLA: Notice of Compliance 5375

Issued May 11, 1994

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
5375
Date
May 11, 1994
Company
Astra Pharma Inc.Mississauga, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
New indications
Therapeutic class
Topical anesthetic for dermal analgesia

Products in this notice

BrandDINStatus today
EMLANot yet assigned—

Medicinal ingredients